Skip to main content
Erschienen in: Orphanet Journal of Rare Diseases 1/2023

Open Access 01.12.2023 | Correction

Correction: Ketogenic diet as a glycine lowering therapy in nonketotic hyperglycinemia and impact on brain glycine levels

verfasst von: Emily Shelkowitz, Russell P. Saneto, Walla Al-Hertani, Charlotte M. A. Lubout, Nicholas V. Stence, Mark S. Brown, Patrick Long, Diana Walleigh, Julie A. Nelson, Francisco E. Perez, Dennis W. W. Shaw, Emma J. Michl, Johan L. K. Van Hove

Erschienen in: Orphanet Journal of Rare Diseases | Ausgabe 1/2023

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN
Hinweise
The original article can be found online at https://​doi.​org/​10.​1186/​s13023-022-02581-6.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Correction : Orphanet Journal of Rare Diseases (2022) 17:423 https://doi.org/10.1186/s13023-022-02581-6
Following publication of the original article [1], we have been notified that reference 33 has error in the published year. The correct reference should be as follows:
33. Bzduch V, Behulova D, Kolnikova M, Payerova J, Fabriciova K. Ketogenic diet in nonketotic hyperglycinemia. J Inherited Metab Dis. 2010;33(Suppl 1):S31.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
download
DOWNLOAD
print
DRUCKEN
Literatur
1.
Zurück zum Zitat Shelkowitz E, Saneto RP, Al-Hertani W, Lubout CMA, Stence NV, Brown MS, Long P, Walleigh D, Nelson JA, Perez FE, Shaw DWW, Michl EJ, Van Hove JLK. Ketogenic diet as a glycine lowering therapy in nonketotic hyperglycinemia and impact on brain glycine levels. Orphanet J Rare Dis. 2022;17:423.CrossRefPubMedPubMedCentral Shelkowitz E, Saneto RP, Al-Hertani W, Lubout CMA, Stence NV, Brown MS, Long P, Walleigh D, Nelson JA, Perez FE, Shaw DWW, Michl EJ, Van Hove JLK. Ketogenic diet as a glycine lowering therapy in nonketotic hyperglycinemia and impact on brain glycine levels. Orphanet J Rare Dis. 2022;17:423.CrossRefPubMedPubMedCentral
Metadaten
Titel
Correction: Ketogenic diet as a glycine lowering therapy in nonketotic hyperglycinemia and impact on brain glycine levels
verfasst von
Emily Shelkowitz
Russell P. Saneto
Walla Al-Hertani
Charlotte M. A. Lubout
Nicholas V. Stence
Mark S. Brown
Patrick Long
Diana Walleigh
Julie A. Nelson
Francisco E. Perez
Dennis W. W. Shaw
Emma J. Michl
Johan L. K. Van Hove
Publikationsdatum
01.12.2023
Verlag
BioMed Central
Erschienen in
Orphanet Journal of Rare Diseases / Ausgabe 1/2023
Elektronische ISSN: 1750-1172
DOI
https://doi.org/10.1186/s13023-023-02646-0

Weitere Artikel der Ausgabe 1/2023

Orphanet Journal of Rare Diseases 1/2023 Zur Ausgabe